RECURRENT OROPHARYNGEAL CARCINOMA
Clinical trials for RECURRENT OROPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OROPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT OROPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pill combo aims to tame recurrent head and neck cancer in rural patients
Disease control Recruiting nowThis study tests whether taking three oral drugs (methotrexate, erlotinib, and celecoxib) together is safe and practical for people with head and neck cancer that has come back or spread. The trial enrolls 25 adults in the rural Midwest and uses virtual visits to reduce travel bu…
Matched conditions: RECURRENT OROPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 15, 2026 10:42 UTC
-
Double vaccine attack: new hope for HPV-Positive throat cancer?
Disease control Recruiting nowThis study tests whether combining two different HPV vaccines with the immunotherapy drug pembrolizumab can help control advanced oropharyngeal (throat) cancer that has spread or returned. About 54 adults with HPV-positive, PD-L1-positive cancer will receive the vaccines and pemb…
Matched conditions: RECURRENT OROPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Michael K. Gibson • Aim: Disease control
Last updated May 07, 2026 18:40 UTC